General Gastro News Articles

Gastro

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lee DK - The authors expect and hope DES will work effectively for tumor cells in diverse ways and, more importantly, will prolong stent patency and the patients’ survival periods. But considerable investigation and a clinical study of DES will be required to achieve these goals.

Exclusive Author Commentary
Dong Ki Lee, 07/01/09

I will continue to develope the DES effectivity by prolonging the drug release. And examine the various chemotherapeutic agent to achieve the ideal DES for the patients with malignat bile duct obstruction. I shall expedite the availability of the DES to the market.

Today in GI Oncology...keeping you current

Anticyclic Citrullinated Peptide Antibody-Positive Paraneoplastic Polyarthritis in a Patient With Metastatic Pancreatic Cancer
The American Journal of the Medical Sciences, 12/18/09

Gastrointestinal stromal tumor (GIST) of the anterior rectal wall
Der Urologe, 12/18/09

Prognostic Significance of Host- and Tumor-Related Factors in Patients with Gastric Cancer
World Journal of Surgery, 12/18/09